Home
About Us
Dove siamo
News & Avvisi
I nostri eventi
Contatti & Social
Multimedia
Optional services
Amazon
Add-On (Option)
[EN] Financial Times
Condividi
post
Johnson & Johnson looking to buy eye disease biotech for up to $3.4bn
Scritto il 16/11/2026
da
Condividi
post
Drugmaker’s potential acquisition of Ollin Biosciences is latest in glut of deals in biotechnology sector